IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study
Leng, Xi-sheng1; Zhao, Yong-jie2; Qiu, Hui-zhong3; Cao, Yong-kuan4; Zhu, Wei-hua1; Shen, Ju-fang5; Paschke, Amanda6; Dai, Wei-min7; Caldwell, Nicole6; Wang, Jue5
关键词Beta-lactams Ceftriaxone Metronidazole
刊名JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
2014-12-01
DOI10.1093/jac/dku302
69期:12页:3379-3386
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Infectious Diseases ; Microbiology ; Pharmacology & Pharmacy
资助者Merck Co., Inc. ; Merck Sharp &amp ; Dohme Corp., China ; Merck Co., Inc. ; Merck Sharp &amp ; Dohme Corp., China
研究领域[WOS]Infectious Diseases ; Microbiology ; Pharmacology & Pharmacy
关键词[WOS]ANTIBIOTIC-PROPHYLAXIS ; CEFOTETAN PROPHYLAXIS ; METRONIDAZOLE ; CEFTRIAXONE ; TRIALS ; RATES
英文摘要

Our purpose was to evaluate ertapenem versus ceftriaxone/metronidazole for prophylaxis of surgical site infections (SSIs) following elective colorectal surgery in Chinese adult patients.

Eligible Chinese adults aged 18-80 years scheduled to undergo elective colorectal surgery by laparotomy were randomized to receive a 30 min infusion of 1 g of ertapenem/metronidazole placebo or 2 g of ceftriaxone/500 mg of metronidazole within 2 h before initial incision. The study endpoint was the proportion of patients with successful prophylaxis at 4 weeks after treatment. The primary analysis was based on the evaluable population (PP population) and the pre-specified non-inferiority margin was set at -15%. ClinicalTrials.gov: NCT01254344.

Of 599 patients randomized, 499 (251 ertapenem and 248 ceftriaxone) were eligible for inclusion in the PP population. The proportions of patients with successful prophylaxis in the ertapenem and ceftriaxone groups were 90.4% (227/251) and 90.3% (224/248), respectively. The difference in the proportion of successful outcomes was 0.1% (95% CI -5.2%, 5.5%). Unexplained antibiotic use was the most frequent reason for prophylaxis failure in both groups [ertapenem 4.8% (12/251), ceftriaxone 4.4% (11/248); difference 0.3%; 95% CI -3.6, 4.3]. Pathogen species isolated from SSI sources were consistent with previously conducted studies and the product package insert. The incidence of adverse events (AEs) was similar between the groups, with the most common AE being pyrexia [ertapenem 7.6% (22/290), ceftriaxone 5.7% (17/297)].

Ertapenem is as effective as ceftriaxone/metronidazole for SSI prophylaxis in patients undergoing elective colorectal surgery, and is well tolerated.

语种英语
资助者Merck Co., Inc. ; Merck Sharp &amp ; Dohme Corp., China ; Merck Co., Inc. ; Merck Sharp &amp ; Dohme Corp., China
WOS记录号WOS:000345767300029
Citation statistics
Cited Times:4[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54758
Collection北京大学第二临床医学院
作者单位1.Peking Univ, Peoples Hosp, Dept Surg, Beijing 100871, Peoples R China
2.Tianjin Peoples Hosp, Dept Surg, Tianjin, Peoples R China
3.Beijing Union Med Coll Hosp, Dept Gen Surg, Beijing, Peoples R China
4.Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Peoples R China
5.MSD China, Shanghai, Peoples R China
6.Merck & Co Inc, Whitehouse Stn, NJ USA
7.PAREXEL Int, Shanghai, Peoples R China
Recommended Citation
GB/T 7714
Leng, Xi-sheng,Zhao, Yong-jie,Qiu, Hui-zhong,et al. Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,2014,69(12):3379-3386.
APA Leng, Xi-sheng.,Zhao, Yong-jie.,Qiu, Hui-zhong.,Cao, Yong-kuan.,Zhu, Wei-hua.,...&Wang, Jue.(2014).Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,69(12),3379-3386.
MLA Leng, Xi-sheng,et al."Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study".JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 69.12(2014):3379-3386.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Leng, Xi-sheng]'s Articles
[Zhao, Yong-jie]'s Articles
[Qiu, Hui-zhong]'s Articles
百度学术
百度学术Similar articles in
[Leng, Xi-sheng]'s Articles
[Zhao, Yong-jie]'s Articles
[Qiu, Hui-zhong]'s Articles
必应学术
必应学术Similar articles in
[Leng, Xi-sheng]'s Articles
[Zhao, Yong-jie]'s Articles
[Qiu, Hui-zhong]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.